Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic
CONCLUSION: Due to the rarity of MBC, this study highlights important findings from real clinical practice. Although the number of patients with MBC with unfavorable features was higher in this Czech dataset than in international studies, the prognosis remains consistent with real-world evidence.PMID:38431780 | DOI:10.1093/oncolo/oyae031
Source: The Oncologist - Category: Cancer & Oncology Authors: Zuzana Bielcikova Milos Holanek Iveta Selingerova Ondrej Sorejs Iveta Kolarova Renata Soumarova Jan Proks Lucie Reifova Vlastimila Cmejlova Lenka Linkova Michaela Zabojnikova Martina Chodacka Lucie Janovska Lenka Lisnerova Karolina Kasparova Denisa Pohank Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Czechia Health | Endocrine Therapy | Genetics | HER2 | Male Breast Cancer | Study